{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:17:23Z","timestamp":1793823443827,"version":"4.6.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82302625"],"award-info":[{"award-number":["82302625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0509500"],"award-info":[{"award-number":["2023ZD0509500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10084-w","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T05:10:16Z","timestamp":1759727416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting Skp2 by Tanshinone IIA overcomes chemoresistance in colorectal cancer"],"prefix":"10.1007","volume":"41","author":[{"given":"Xin","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanquan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"10084_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41420-024-02040-0","volume":"10","author":"G Acharya","year":"2024","unstructured":"Acharya G, Mani C, Sah N, et al. Chk1 inhibitor induced parylation by targeting parg causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer. Cell Death Discov. 2024;10:278. https:\/\/doi.org\/10.1038\/s41420-024-02040-0.","journal-title":"Cell Death Discov"},{"key":"10084_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030982","author":"J Afonso","year":"2023","unstructured":"Afonso J, Gon\u00e7alves C, Costa M, et al. Glucose metabolism reprogramming in bladder cancer: Hexokinase 2 (hk2) as prognostic biomarker and target for bladder cancer therapy. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15030982.","journal-title":"Cancers (Basel)"},{"key":"10084_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105364","volume":"164","author":"MA Ansari","year":"2021","unstructured":"Ansari MA, Khan FB, Safdari HA, et al. Prospective therapeutic potential of tanshinone IIA: an updated overview. Pharmacol Res. 2021;164:105364. https:\/\/doi.org\/10.1016\/j.phrs.2020.105364.","journal-title":"Pharmacol Res"},{"key":"10084_CR4","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.2021.6021","volume":"325","author":"J Bien","year":"2021","unstructured":"Bien J, Lin A. A review of the diagnosis and treatment of metastatic colorectal cancer. JAMA. 2021;325:2404\u20135. https:\/\/doi.org\/10.1001\/jama.2021.6021.","journal-title":"JAMA"},{"key":"10084_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcancer.2020.01.013","volume":"67","author":"Z Cai","year":"2020","unstructured":"Cai Z, Moten A, Peng D, et al. The skp2 pathway: a critical target for cancer therapy. Semin Cancer Biol. 2020;67:16\u201333. https:\/\/doi.org\/10.1016\/j.semcancer.2020.01.013.","journal-title":"Semin Cancer Biol"},{"key":"10084_CR6","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2012.02.065","volume":"149","author":"C-H Chan","year":"2012","unstructured":"Chan C-H, Li C-F, Yang W-L, et al. The skp2-SCF E3 ligase regulates akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell. 2012;149:1098\u2013111. https:\/\/doi.org\/10.1016\/j.cell.2012.02.065.","journal-title":"Cell"},{"key":"10084_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2013.06.048","volume":"154","author":"C-H Chan","year":"2013","unstructured":"Chan C-H, Morrow JK, Li C-F, et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell. 2013;154:556\u201368. https:\/\/doi.org\/10.1016\/j.cell.2013.06.048.","journal-title":"Cell"},{"key":"10084_CR8","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.2147\/CMAR.S253367","volume":"12","author":"X Chen","year":"2020","unstructured":"Chen X, Huang Z, Wu W, et al. Inhibition of skp2 sensitizes chronic myeloid leukemia cells to imatinib. Cancer Manag Res. 2020;12:4777\u201387. https:\/\/doi.org\/10.2147\/CMAR.S253367.","journal-title":"Cancer Manag Res"},{"key":"10084_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s12935-021-02312-0","volume":"21","author":"Q Chen","year":"2021","unstructured":"Chen Q, Li L, Liu X, et al. Hexokinases 2 promoted cell motility and distant metastasis by elevating fibronectin through akt1\/p-akt1 in cervical cancer cells. Cancer Cell Int. 2021;21:600. https:\/\/doi.org\/10.1186\/s12935-021-02312-0.","journal-title":"Cancer Cell Int"},{"key":"10084_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188797","volume":"1877","author":"J Chen","year":"2022","unstructured":"Chen J, Zhu H, Yin Y, et al. Colorectal cancer: Metabolic interactions reshape the tumor microenvironment. Biochimica et Biophysica Acta (BBA). 2022;1877:188797. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188797.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"10084_CR11","doi-asserted-by":"publisher","first-page":"156702","DOI":"10.1016\/j.phymed.2025.156702","volume":"141","author":"S Chen","year":"2025","unstructured":"Chen S, Li P, Shi K, et al. Tanshinone IIA promotes ferroptosis in cutaneous melanoma via stat1-mediated upregulation of ptgs2 expression. Phytomedicine. 2025;141:156702. https:\/\/doi.org\/10.1016\/j.phymed.2025.156702.","journal-title":"Phytomedicine"},{"key":"10084_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094716","author":"F Ciscato","year":"2021","unstructured":"Ciscato F, Ferrone L, Masgras I, et al. Hexokinase 2 in cancer: a prima donna playing multiple characters. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094716.","journal-title":"Int J Mol Sci"},{"key":"10084_CR13","doi-asserted-by":"publisher","first-page":"24628","DOI":"10.1074\/jbc.M116.738567","volume":"291","author":"MI Davis","year":"2016","unstructured":"Davis MI, Pragani R, Fox JT, et al. Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models. J Biol Chem. 2016;291:24628\u201340. https:\/\/doi.org\/10.1074\/jbc.M116.738567.","journal-title":"J Biol Chem"},{"key":"10084_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194874","author":"S Deng","year":"2022","unstructured":"Deng S, Vlatkovic T, Li M, et al. Targeting the DNA damage response and DNA repair pathways to enhance radiosensitivity in colorectal cancer. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194874.","journal-title":"Cancers (Basel)"},{"key":"10084_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111177","volume":"40","author":"KB Emdal","year":"2022","unstructured":"Emdal KB, Palacio-Escat N, Wigerup C, et al. Phosphoproteomics of primary aml patient samples reveals rationale for akt combination therapy and p53 context to overcome selinexor resistance. Cell Rep. 2022;40:111177. https:\/\/doi.org\/10.1016\/j.celrep.2022.111177.","journal-title":"Cell Rep"},{"key":"10084_CR16","doi-asserted-by":"publisher","first-page":"611087","DOI":"10.3389\/fphar.2020.611087","volume":"11","author":"Z-Y Fang","year":"2020","unstructured":"Fang Z-Y, Zhang M, Liu J-N, et al. Tanshinone iia: A review of its anticancer effects. Front Pharmacol. 2020;11:611087. https:\/\/doi.org\/10.3389\/fphar.2020.611087.","journal-title":"Front Pharmacol"},{"key":"10084_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrc2396","volume":"8","author":"D Frescas","year":"2008","unstructured":"Frescas D, Pagano M. Deregulated proteolysis by the f-box proteins Skp2 and beta-Trcp: tipping the scales of cancer. Nat Rev Cancer. 2008;8:438\u201349. https:\/\/doi.org\/10.1038\/nrc2396.","journal-title":"Nat Rev Cancer"},{"key":"10084_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231710037","author":"A Fukushi","year":"2022","unstructured":"Fukushi A, Kim H-D, Chang Y-C, et al. Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231710037.","journal-title":"Int J Mol Sci"},{"key":"10084_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1142\/s0192415x23500349","volume":"51","author":"Y Gan","year":"2023","unstructured":"Gan Y, Zhou L, Wang R, et al. Curcumol reduces aerobic glycolysis and overcomes chemoresistance by inducing cdh1-mediated skp2 ubiquitination. Am J Chin Med. 2023;51:723\u201340. https:\/\/doi.org\/10.1142\/s0192415x23500349.","journal-title":"Am J Chin Med"},{"key":"10084_CR20","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1515\/med-2022-0512","volume":"17","author":"T Ge","year":"2022","unstructured":"Ge T, Zhang Y. Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p\/aven axis. Open Med (Wars). 2022;17:1228\u201340. https:\/\/doi.org\/10.1515\/med-2022-0512.","journal-title":"Open Med (Wars)"},{"key":"10084_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-017-0649-0","volume":"16","author":"Q Geng","year":"2017","unstructured":"Geng Q, Liu J, Gong Z, et al. Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer. Mol Cancer. 2017;16:83. https:\/\/doi.org\/10.1186\/s12943-017-0649-0.","journal-title":"Mol Cancer"},{"key":"10084_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41416-022-01898-0","volume":"127","author":"P Gupta","year":"2022","unstructured":"Gupta P, Zhao H, Hoang B, et al. Targeting the untargetable: Rb1-deficient tumours are vulnerable to skp2 ubiquitin ligase inhibition. Br J Cancer. 2022;127:969\u201375. https:\/\/doi.org\/10.1038\/s41416-022-01898-0.","journal-title":"Br J Cancer"},{"key":"10084_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/cncr.23317","volume":"112","author":"DD Hershko","year":"2008","unstructured":"Hershko DD. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Cancer. 2008;112:1415\u201324. https:\/\/doi.org\/10.1002\/cncr.23317.","journal-title":"Cancer"},{"key":"10084_CR24","doi-asserted-by":"publisher","unstructured":"Hodeib H, Abd El Hai D, Tawfik MA, et al. The impact of skp2 gene expression in chronic myeloid leukemia. Genes 2022;13. https:\/\/doi.org\/10.3390\/genes13060948","DOI":"10.3390\/genes13060948"},{"key":"10084_CR25","doi-asserted-by":"publisher","first-page":"e2100738","DOI":"10.1002\/mnfr.202100738","volume":"66","author":"L Huang","year":"2022","unstructured":"Huang L, He C, Zheng S, et al. Akt1\/hk2 axis-mediated glucose metabolism: A novel therapeutic target of sulforaphane in bladder cancer. Mol Nutr Food Res. 2022a;66:e2100738. https:\/\/doi.org\/10.1002\/mnfr.202100738.","journal-title":"Mol Nutr Food Res"},{"key":"10084_CR26","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1186\/s12885-022-10001-y","volume":"22","author":"Y Huang","year":"2022","unstructured":"Huang Y, Ouyang F, Yang F, et al. The expression of hexokinase 2 and its hub genes are correlated with the prognosis in glioma. BMC Cancer. 2022b;22:900. https:\/\/doi.org\/10.1186\/s12885-022-10001-y.","journal-title":"BMC Cancer"},{"key":"10084_CR27","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.2147\/CMAR.S251223","volume":"12","author":"R Hull","year":"2020","unstructured":"Hull R, Francies FZ, Oyomno M, et al. Colorectal cancer genetics, incidence and risk factors: in search for targeted therapies. Cancer Manag Res. 2020;12:9869\u201382. https:\/\/doi.org\/10.2147\/CMAR.S251223.","journal-title":"Cancer Manag Res"},{"key":"10084_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/genes13030549","author":"M Ishfaq","year":"2022","unstructured":"Ishfaq M, Bashir N, Riaz SK, et al. Expression of hk2, pkm2, and pfkm is associated with metastasis and late disease onset in breast cancer patients. Genes. 2022. https:\/\/doi.org\/10.3390\/genes13030549.","journal-title":"Genes"},{"key":"10084_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang H, Wei H, Wang H, et al. Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer. Cell Death Dis. 2022a;13:206. https:\/\/doi.org\/10.1038\/s41419-022-04632-z.","journal-title":"Cell Death Dis"},{"key":"10084_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1000563","volume":"9","author":"X Jiang","year":"2022","unstructured":"Jiang X, Jiang Z, Cheng Q, et al. Cholecystectomy promotes the development of colorectal cancer by the alternation of bile acid metabolism and the gut microbiota. Front Med. 2022b;9:1000563. https:\/\/doi.org\/10.3389\/fmed.2022.1000563.","journal-title":"Front Med"},{"key":"10084_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153707","author":"MS Kavitha","year":"2022","unstructured":"Kavitha MS, Gangadaran P, Jackson A, et al. Deep neural network models for colon cancer screening. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14153707.","journal-title":"Cancers (Basel)"},{"key":"10084_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jep.2008.09.013","volume":"120","author":"M-H Li","year":"2008","unstructured":"Li M-H, Chen J-M, Peng Y, et al. Investigation of danshen and related medicinal plants in China. J Ethnopharmacol. 2008;120:419\u201326. https:\/\/doi.org\/10.1016\/j.jep.2008.09.013.","journal-title":"J Ethnopharmacol"},{"key":"10084_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41419-020-2579-9","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Gao F, Zhao Q, et al. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing akt-c-myc signaling-mediated aerobic glycolysis. Cell Death Dis. 2020;11:381. https:\/\/doi.org\/10.1038\/s41419-020-2579-9.","journal-title":"Cell Death Dis"},{"key":"10084_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41419-022-04973-9","volume":"13","author":"P Li","year":"2022","unstructured":"Li P, Chen T, Kuang P, et al. Aurora-A\/FOXO3A\/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting aurora-A\/SKP2 shows synthetic lethality. Cell Death Dis. 2022a;13:606. https:\/\/doi.org\/10.1038\/s41419-022-04973-9.","journal-title":"Cell Death Dis"},{"key":"10084_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.967229","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Ye D, Zhou W, et al. Alcohol consumption and colorectal cancer risk: a mendelian randomization study. Front Genet. 2022b;13:967229. https:\/\/doi.org\/10.3389\/fgene.2022.967229.","journal-title":"Front Genet"},{"key":"10084_CR36","doi-asserted-by":"publisher","first-page":"e2106046","DOI":"10.1002\/smll.202106046","volume":"18","author":"H Liang","year":"2022","unstructured":"Liang H, Zhang F, Hong Y, et al. Synergistic silencing of skp2 by sirna self-assembled nanoparticles as a therapeutic strategy for advanced prostate cancer. Small. 2022;18:e2106046. https:\/\/doi.org\/10.1002\/smll.202106046.","journal-title":"Small"},{"key":"10084_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-019-0092-z","volume":"5","author":"Y Liao","year":"2019","unstructured":"Liao Y, Liu N, Xia X, et al. Usp10 modulates the skp2\/bcr-abl axis via stabilizing skp2 in chronic myeloid leukemia. Cell Discov. 2019;5:24. https:\/\/doi.org\/10.1038\/s41421-019-0092-z.","journal-title":"Cell Discov"},{"key":"10084_CR38","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.7150\/ijbs.37481","volume":"15","author":"W Liu","year":"2019","unstructured":"Liu W, Li W, Liu H, et al. Xanthohumol inhibits colorectal cancer cells via downregulation of hexokinases II-mediated glycolysis. Int J Biol Sci. 2019;15:2497\u2013508. https:\/\/doi.org\/10.7150\/ijbs.37481.","journal-title":"Int J Biol Sci"},{"key":"10084_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2022.109389","volume":"729","author":"C Liu","year":"2022","unstructured":"Liu C, Li Y, Dong C, et al. E6e7 regulates the hk2 expression in cervical cancer via gsk3\u03b2\/fto signal. Arch Biochem Biophys. 2022a;729:109389. https:\/\/doi.org\/10.1016\/j.abb.2022.109389.","journal-title":"Arch Biochem Biophys"},{"key":"10084_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106259","volume":"181","author":"J Liu","year":"2022","unstructured":"Liu J, Zheng X, Li W, et al. Anti-tumor effects of SKP2 inhibitor aaa-237 on NSCLC by arresting cell cycle at G0\/G1 phase and inducing senescence. Pharmacol Res. 2022b;181:106259. https:\/\/doi.org\/10.1016\/j.phrs.2022.106259.","journal-title":"Pharmacol Res"},{"key":"10084_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441\u201364. https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154237.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10084_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2008.11.006","volume":"19","author":"SP Mathupala","year":"2009","unstructured":"Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: Cancer\u2019s stygian link to the \u201cwarburg effect\u201d and a pivotal target for effective therapy. Semin Cancer Biol. 2009;19:17\u201324. https:\/\/doi.org\/10.1016\/j.semcancer.2008.11.006.","journal-title":"Semin Cancer Biol"},{"key":"10084_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071360","author":"CC Okechukwu","year":"2024","unstructured":"Okechukwu CC, Ma X, Sah N, et al. Enhanced therapeutic efficacy of the nanoscale fluoropyrimidine polymer CF10 in a rat colorectal cancer liver metastasis model. Cancers. 2024. https:\/\/doi.org\/10.3390\/cancers16071360.","journal-title":"Cancers"},{"key":"10084_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032809","author":"E Paccosi","year":"2023","unstructured":"Paccosi E, Balzerano A, Proietti-De-Santis L. Interfering with the ubiquitin-mediated regulation of akt as a strategy for cancer treatment. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032809.","journal-title":"Int J Mol Sci"},{"key":"10084_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113145","volume":"151","author":"M Pe\u00f1a","year":"2022","unstructured":"Pe\u00f1a M, Guzm\u00e1n A, Mart\u00ednez R, et al. Preventive effects of Brassicaceae family for colon cancer prevention: a focus on in vitro studies. Biomed Pharmacother. 2022;151:113145. https:\/\/doi.org\/10.1016\/j.biopha.2022.113145.","journal-title":"Biomed Pharmacother"},{"key":"10084_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/cdd.2014.173","volume":"22","author":"DJ Roberts","year":"2015","unstructured":"Roberts DJ, Miyamoto S. Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and torcing to autophagy. Cell Death Differ. 2015;22:248\u201357. https:\/\/doi.org\/10.1038\/cdd.2014.173.","journal-title":"Cell Death Differ"},{"key":"10084_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/emboj.2008.6","volume":"27","author":"G Rodier","year":"2008","unstructured":"Rodier G, Coulombe P, Tanguay PL, et al. Phosphorylation of skp2 regulated by cdk2 and cdc14b protects it from degradation by apc(cdh1) in g1 phase. EMBO J. 2008;27:679\u201391. https:\/\/doi.org\/10.1038\/emboj.2008.6.","journal-title":"EMBO J"},{"key":"10084_CR48","doi-asserted-by":"publisher","unstructured":"Sah N, Luna P, Mani C, et al. A novel second-generation nano-fluoropyrimidine to treat metastatic colorectal cancer and overcome 5-fluorouracil resistance. Cancer Research 2023;83. https:\/\/doi.org\/10.1158\/1538-7445.Am2023-6178","DOI":"10.1158\/1538-7445.Am2023-6178"},{"key":"10084_CR49","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41419-022-04891-w","volume":"13","author":"K Seiler","year":"2022","unstructured":"Seiler K, Humbert M, Minder P, et al. Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions. Cell Death Dis. 2022;13:448. https:\/\/doi.org\/10.1038\/s41419-022-04891-w.","journal-title":"Cell Death Dis"},{"key":"10084_CR50","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1016\/j.drudis.2022.05.017","volume":"27","author":"W Shan","year":"2022","unstructured":"Shan W, Zhou Y, Tam KY. The development of small-molecule inhibitors targeting hexokinase 2. Drug Discov Today. 2022;27:2574\u201385. https:\/\/doi.org\/10.1016\/j.drudis.2022.05.017.","journal-title":"Drug Discov Today"},{"key":"10084_CR51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1272\/jnms.JNMS.2022_89-310","volume":"89","author":"S Shinji","year":"2022","unstructured":"Shinji S, Yamada T, Matsuda A, et al. Recent advances in the treatment of colorectal cancer: a review. J Nippon Med Sch. 2022;89:246\u201354. https:\/\/doi.org\/10.1272\/jnms.JNMS.2022_89-310.","journal-title":"J Nippon Med Sch"},{"key":"10084_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mito.2021.09.013","volume":"61","author":"G Swargiary","year":"2021","unstructured":"Swargiary G, Mani S. Molecular docking and simulation studies of phytocompounds derived from Centella asiatica and Andrographis paniculata against hexokinase ii as mitocan agents. Mitochondrion. 2021;61:138\u201346. https:\/\/doi.org\/10.1016\/j.mito.2021.09.013.","journal-title":"Mitochondrion"},{"key":"10084_CR53","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41419-022-04727-7","volume":"13","author":"J Tantai","year":"2022","unstructured":"Tantai J, Pan X, Chen Y, et al. Trim46 activates akt\/hk2 signaling by modifying phlpp2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells. Cell Death Dis. 2022;13:285. https:\/\/doi.org\/10.1038\/s41419-022-04727-7.","journal-title":"Cell Death Dis"},{"key":"10084_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-022-00860-9","volume":"29","author":"P-J Tsai","year":"2022","unstructured":"Tsai P-J, Lai Y-H, Manne RK, et al. Akt: a key transducer in cancer. J Biomed Sci. 2022;29:76. https:\/\/doi.org\/10.1186\/s12929-022-00860-9.","journal-title":"J Biomed Sci"},{"key":"10084_CR55","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG VanDer Heiden","year":"2009","unstructured":"VanDer Heiden MG, Cantley LC, Thompson CB. Understanding the warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333. https:\/\/doi.org\/10.1126\/science.1160809.","journal-title":"Science"},{"key":"10084_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04568-0","author":"H Wang","year":"2022","unstructured":"Wang H, Pan W. Challenges of chimeric antigen receptor-T\/natural killer cell therapy in the treatment of solid tumors: focus on colorectal cancer and evaluation of combination therapies. Mol Cell Biochem. 2022. https:\/\/doi.org\/10.1007\/s11010-022-04568-0.","journal-title":"Mol Cell Biochem"},{"key":"10084_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051147","author":"T Wu","year":"2021","unstructured":"Wu T, Gu X, Cui H. Emerging roles of skp2 in cancer drug resistance. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10051147.","journal-title":"Cells"},{"key":"10084_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106123","volume":"142","author":"Q Wu","year":"2022","unstructured":"Wu Q, Wang SP, Sun XX, et al. Huachansu suppresses tumor growth and interferes with glucose metabolism in hepatocellular carcinoma cells by restraining hexokinase-2. Int J Biochem Cell Biol. 2022;142:106123. https:\/\/doi.org\/10.1016\/j.biocel.2021.106123.","journal-title":"Int J Biochem Cell Biol"},{"key":"10084_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14:101174. https:\/\/doi.org\/10.1016\/j.tranon.2021.101174.","journal-title":"Transl Oncol"},{"key":"10084_CR60","doi-asserted-by":"publisher","first-page":"14002","DOI":"10.1038\/ncomms14002","volume":"8","author":"J Xu","year":"2017","unstructured":"Xu J, Zhou W, Yang F, et al. The \u03b2-trcp-fbxw2-skp2 axis regulates lung cancer cell growth with fbxw2 acting as a tumour suppressor. Nat Commun. 2017;8:14002. https:\/\/doi.org\/10.1038\/ncomms14002.","journal-title":"Nat Commun"},{"key":"10084_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41419-020-03312-0","volume":"12","author":"Z Xu","year":"2021","unstructured":"Xu Z, Jia K, Wang H, et al. Mettl14-regulated pi3k\/akt signaling pathway via pten affects hdac5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease. Cell Death Dis. 2021;12:32. https:\/\/doi.org\/10.1038\/s41419-020-03312-0.","journal-title":"Cell Death Dis"},{"key":"10084_CR62","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/cbr.2019.2787","volume":"34","author":"W Yan","year":"2019","unstructured":"Yan W, Yang Y, Yang W. Inhibition of skp2 activity impaired atm-mediated DNA repair and enhanced sensitivity of cisplatin-resistant mantle cell lymphoma cells. Cancer Biother Radiopharm. 2019;34:451\u20138. https:\/\/doi.org\/10.1089\/cbr.2019.2787.","journal-title":"Cancer Biother Radiopharm"},{"key":"10084_CR63","doi-asserted-by":"publisher","first-page":"1001444","DOI":"10.3389\/fimmu.2022.1001444","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Wu G, Zhang X, et al. Current progress and future perspectives of neoadjuvant anti-PD-1\/PD-L1 therapy for colorectal cancer. Front Immunol. 2022;13:1001444. https:\/\/doi.org\/10.3389\/fimmu.2022.1001444.","journal-title":"Front Immunol"},{"key":"10084_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00869-3","volume":"13","author":"X Yu","year":"2020","unstructured":"Yu X, Li W, Liu H, et al. Ubiquitination of the DNA-damage checkpoint kinase chk1 by traf4 is required for chk1 activation. J Hematol Oncol. 2020;13:40. https:\/\/doi.org\/10.1186\/s13045-020-00869-3.","journal-title":"J Hematol Oncol"},{"key":"10084_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04394-0","volume":"13","author":"H Yu","year":"2021","unstructured":"Yu H, Yang W, Huang J, et al. Gpr120 induces regulatory dendritic cells by inhibiting hk2-dependent glycolysis to alleviate fulminant hepatic failure. Cell Death Dis. 2021;13:1. https:\/\/doi.org\/10.1038\/s41419-021-04394-0.","journal-title":"Cell Death Dis"},{"key":"10084_CR66","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-022-04685-0","volume":"13","author":"X Yu","year":"2022","unstructured":"Yu X, Zhou L, Liu W, et al. Skp2 stabilizes mcl-1 and confers radioresistance in colorectal cancer. Cell Death Dis. 2022;13:249. https:\/\/doi.org\/10.1038\/s41419-022-04685-0.","journal-title":"Cell Death Dis"},{"key":"10084_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101109","volume":"297","author":"F Zhang","year":"2021","unstructured":"Zhang F, Zhao Y, Sun Y. Usp2 is an skp2 deubiquitylase that stabilizes both skp2 and its substrates. J Biol Chem. 2021;297:101109. https:\/\/doi.org\/10.1016\/j.jbc.2021.101109.","journal-title":"J Biol Chem"},{"key":"10084_CR68","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.2147\/OTT.S203888","volume":"12","author":"H Zhao","year":"2019","unstructured":"Zhao H, Pan H, Wang H, et al. Skp2 targeted inhibition suppresses human uveal melanoma progression by blocking ubiquitylation of p27. OncoTargets Ther. 2019;12:4297\u2013308. https:\/\/doi.org\/10.2147\/OTT.S203888.","journal-title":"OncoTargets Ther"},{"key":"10084_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105367","volume":"164","author":"M Zheng","year":"2021","unstructured":"Zheng M, Wu C, Yang K, et al. Novel selective hexokinase 2 inhibitor benitrobenrazide blocks cancer cells growth by targeting glycolysis. Pharmacol Res. 2021;164:105367. https:\/\/doi.org\/10.1016\/j.phrs.2020.105367.","journal-title":"Pharmacol Res"},{"key":"10084_CR70","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/13543776.2022.2027912","volume":"32","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Guo Y, Tam KY. Targeting glucose metabolism to develop anticancer treatments and therapeutic patents. Expert Opin Ther Pat. 2022;32:441\u201353. https:\/\/doi.org\/10.1080\/13543776.2022.2027912.","journal-title":"Expert Opin Ther Pat"},{"key":"10084_CR71","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41419-022-05477-2","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Yue P, Dickinson CF, et al. Natural product preferentially targets redox and metabolic adaptations and aberrantly active stat3 to inhibit breast tumor growth in vivo. Cell Death Dis. 2022;13:1022. https:\/\/doi.org\/10.1038\/s41419-022-05477-2","journal-title":"Cell Death Dis"},{"key":"10084_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154083","volume":"238","author":"J Zou","year":"2022","unstructured":"Zou J, Lin Y, Hu M, et al. N-myc transcriptionally activates skp2 to suppress p27 expression in small cell lung cancer. Pathol Res Pract. 2022;238:154083. https:\/\/doi.org\/10.1016\/j.prp.2022.154083.","journal-title":"Pathol Res Pract"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10084-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10084-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10084-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:03:08Z","timestamp":1759773788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10084-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10084"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10084-w","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee (No. 202009655) of Central South University (Changsha, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}